Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

RSS icon
Thumbnail

The Case for More FFR Utilization in the Cardiac Cath Lab

Momentum is spurring greater use of FFR in the evaluation and treatment of CAD.

Thumbnail

Are Powerful Tools Reshaping Decision-making in the Cath Lab?

How will the debate over when to use FFR, IVUS and OCT play out?

Thumbnail

Do-Better or Do-Over? Cath Lab Safety May Be Ready for a Reboot

Instead of improving fluoroscopy, should interventional cardiologists and radiologists be focusing on change?

Thumbnail

Inside the Cath Lab: Tracking Supplies, Cutting Costs

Cardinal Health

Balancing needs, utilization and cost while improving patient care are central to the mission of the interventional cardiology team at Emory Saint Joseph’s Hospital in Atlanta.

Thumbnail

Paris Cardiology Center Improves Cath Lab Offering with Toshiba’s Cardiovascular X-ray

Infinix Elite’s Image Quality and Versatility Enables Paris Cardiology to Bring Better Care to Multi-State Patient Population.

Thumbnail

Adopting Structured Reporting in the Cath Lab: Strategies that Work

Making the change to structured reporting in the cath lab is not easy, simple, fast or fun. But it can be done, according to interventional cardiologists who have taken the challenge and succeeded.

IN.PACT Admiral Drug-Coated Balloon Cost-Effectiveness Study and Global Study Results of In-Stent Restenosis Population Highlighted in Late Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) adds to the robust data for its IN.PACT® Admiral® drug-coated balloon (DCB)  with the presentation of both its formal cost-effectiveness analysis from the U.S. cohort of the IN.PACT SFA Trial and clinical results from the in-stent restenosis cohort data from Medtronic's IN.PACT Global Study. 

Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.

Displaying 473 - 480 of 569

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.